Philip Reigan
Concepts (383)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thymidine Phosphorylase | 7 | 2022 | 12 | 2.620 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 4 | 2021 | 13 | 2.180 |
Why?
| Antineoplastic Agents | 16 | 2020 | 1990 | 2.160 |
Why?
| Protein Kinase Inhibitors | 8 | 2021 | 833 | 1.960 |
Why?
| Pyrimidines | 6 | 2021 | 388 | 1.920 |
Why?
| Protein-Tyrosine Kinases | 6 | 2019 | 442 | 1.700 |
Why?
| Nuclear Proteins | 6 | 2018 | 618 | 1.530 |
Why?
| Cell Cycle Proteins | 5 | 2018 | 576 | 1.510 |
Why?
| Enzyme Inhibitors | 9 | 2021 | 836 | 1.320 |
Why?
| Glioblastoma | 3 | 2022 | 262 | 1.230 |
Why?
| STAT3 Transcription Factor | 3 | 2022 | 193 | 1.180 |
Why?
| Pyrazoles | 4 | 2018 | 366 | 1.080 |
Why?
| Models, Molecular | 25 | 2021 | 1443 | 1.050 |
Why?
| Neoplasms | 5 | 2023 | 2235 | 1.030 |
Why?
| Pyrroles | 2 | 2021 | 199 | 0.960 |
Why?
| Prodrugs | 4 | 2007 | 44 | 0.870 |
Why?
| NAD(P)H Dehydrogenase (Quinone) | 8 | 2011 | 33 | 0.820 |
Why?
| Pyrimidinones | 4 | 2018 | 88 | 0.820 |
Why?
| Purines | 1 | 2021 | 166 | 0.740 |
Why?
| Pteridines | 1 | 2020 | 16 | 0.730 |
Why?
| Cell Survival | 8 | 2022 | 1075 | 0.700 |
Why?
| Structure-Activity Relationship | 10 | 2020 | 536 | 0.690 |
Why?
| Drug Resistance, Neoplasm | 4 | 2021 | 673 | 0.690 |
Why?
| Small Molecule Libraries | 2 | 2016 | 83 | 0.690 |
Why?
| Indolequinones | 5 | 2011 | 5 | 0.670 |
Why?
| AMP-Activated Protein Kinases | 1 | 2020 | 179 | 0.670 |
Why?
| Aldehydes | 8 | 2014 | 155 | 0.630 |
Why?
| HSP90 Heat-Shock Proteins | 5 | 2011 | 46 | 0.620 |
Why?
| Protein Binding | 12 | 2021 | 2010 | 0.600 |
Why?
| Brain Neoplasms | 3 | 2020 | 1016 | 0.600 |
Why?
| Medulloblastoma | 2 | 2016 | 177 | 0.580 |
Why?
| Glutamate-Cysteine Ligase | 2 | 2013 | 18 | 0.570 |
Why?
| Cell Line, Tumor | 18 | 2022 | 2904 | 0.560 |
Why?
| Xanthine Oxidase | 2 | 2007 | 82 | 0.550 |
Why?
| Protein Isoforms | 1 | 2017 | 347 | 0.550 |
Why?
| Benzoquinones | 4 | 2011 | 45 | 0.540 |
Why?
| Uracil | 3 | 2021 | 35 | 0.520 |
Why?
| Isoxazoles | 5 | 2023 | 56 | 0.500 |
Why?
| Cisplatin | 1 | 2016 | 269 | 0.500 |
Why?
| Hydroquinones | 3 | 2011 | 25 | 0.480 |
Why?
| Lactams, Macrocyclic | 3 | 2011 | 48 | 0.470 |
Why?
| Deoxyribose | 1 | 2013 | 5 | 0.470 |
Why?
| Drug Screening Assays, Antitumor | 5 | 2020 | 190 | 0.450 |
Why?
| Glutathione | 2 | 2011 | 327 | 0.440 |
Why?
| Molecular Structure | 5 | 2020 | 463 | 0.390 |
Why?
| Molecular Docking Simulation | 6 | 2023 | 102 | 0.380 |
Why?
| Humans | 56 | 2023 | 122796 | 0.380 |
Why?
| Catalytic Domain | 5 | 2021 | 210 | 0.350 |
Why?
| Protein Conformation | 4 | 2021 | 851 | 0.350 |
Why?
| Cell Line | 5 | 2022 | 2785 | 0.340 |
Why?
| Cell Proliferation | 10 | 2020 | 2328 | 0.340 |
Why?
| Glucose | 2 | 2013 | 968 | 0.330 |
Why?
| Imidazoles | 3 | 2021 | 234 | 0.330 |
Why?
| Molecular Targeted Therapy | 3 | 2016 | 361 | 0.330 |
Why?
| Aldehyde Dehydrogenase | 3 | 2014 | 135 | 0.330 |
Why?
| Proto-Oncogene Proteins B-raf | 2 | 2021 | 204 | 0.320 |
Why?
| Amides | 2 | 2020 | 88 | 0.310 |
Why?
| Growth Inhibitors | 1 | 2007 | 44 | 0.300 |
Why?
| Signal Transduction | 6 | 2022 | 4902 | 0.300 |
Why?
| Thyroid Neoplasms | 2 | 2021 | 277 | 0.290 |
Why?
| Proto-Oncogene Proteins c-akt | 4 | 2013 | 433 | 0.290 |
Why?
| src Homology Domains | 2 | 2016 | 54 | 0.280 |
Why?
| Pancreatic Neoplasms | 4 | 2009 | 803 | 0.280 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2023 | 466 | 0.260 |
Why?
| Binding Sites | 6 | 2018 | 1247 | 0.260 |
Why?
| Molecular Dynamics Simulation | 3 | 2023 | 214 | 0.260 |
Why?
| Pyrrolidines | 1 | 2004 | 57 | 0.250 |
Why?
| G-Quadruplexes | 2 | 2022 | 15 | 0.250 |
Why?
| Animals | 27 | 2022 | 34133 | 0.240 |
Why?
| Thymidine | 2 | 2022 | 64 | 0.230 |
Why?
| Rifabutin | 3 | 2008 | 6 | 0.230 |
Why?
| Polycomb Repressive Complex 1 | 1 | 2023 | 51 | 0.220 |
Why?
| DNA | 3 | 2016 | 1401 | 0.220 |
Why?
| Liver Diseases, Alcoholic | 2 | 2014 | 88 | 0.220 |
Why?
| Amino Acid Transport System ASC | 1 | 2022 | 9 | 0.210 |
Why?
| Ear Diseases | 1 | 2022 | 15 | 0.210 |
Why?
| K562 Cells | 2 | 2020 | 75 | 0.210 |
Why?
| Virus Internalization | 1 | 2022 | 42 | 0.210 |
Why?
| Minor Histocompatibility Antigens | 1 | 2022 | 42 | 0.210 |
Why?
| Models, Chemical | 1 | 2023 | 273 | 0.210 |
Why?
| Catalysis | 3 | 2013 | 295 | 0.210 |
Why?
| Drug Synergism | 3 | 2021 | 346 | 0.200 |
Why?
| Quinone Reductases | 2 | 2011 | 15 | 0.200 |
Why?
| Fluorouracil | 1 | 2022 | 160 | 0.200 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 2022 | 122 | 0.200 |
Why?
| Maneb | 1 | 2020 | 7 | 0.200 |
Why?
| Receptors, Androgen | 1 | 2022 | 136 | 0.190 |
Why?
| Heterocyclic Compounds | 1 | 2020 | 21 | 0.190 |
Why?
| Lipoprotein Lipase | 1 | 2020 | 69 | 0.190 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 159 | 0.190 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 179 | 0.180 |
Why?
| Dose-Response Relationship, Drug | 3 | 2020 | 1981 | 0.180 |
Why?
| Fluorescence | 1 | 2020 | 164 | 0.180 |
Why?
| Neovascularization, Pathologic | 1 | 2022 | 292 | 0.180 |
Why?
| Polymorphism, Genetic | 2 | 2014 | 666 | 0.180 |
Why?
| Mice | 17 | 2022 | 15888 | 0.180 |
Why?
| Adenocarcinoma, Follicular | 1 | 2019 | 34 | 0.170 |
Why?
| Amino Acid Sequence | 8 | 2014 | 2123 | 0.170 |
Why?
| Chromatography, High Pressure Liquid | 5 | 2013 | 493 | 0.170 |
Why?
| Thyroid Carcinoma, Anaplastic | 1 | 2019 | 37 | 0.170 |
Why?
| Protein Carbonylation | 3 | 2013 | 52 | 0.170 |
Why?
| Enzyme Assays | 1 | 2018 | 24 | 0.160 |
Why?
| CDC2 Protein Kinase | 1 | 2018 | 27 | 0.160 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2018 | 39 | 0.160 |
Why?
| Pyridazines | 1 | 2018 | 53 | 0.160 |
Why?
| Neoplastic Stem Cells | 1 | 2022 | 340 | 0.160 |
Why?
| Antigens, Neoplasm | 2 | 2011 | 228 | 0.160 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 243 | 0.160 |
Why?
| Escherichia coli | 4 | 2006 | 767 | 0.160 |
Why?
| Phosphorylation | 3 | 2018 | 1733 | 0.150 |
Why?
| Dihydropyridines | 1 | 2017 | 16 | 0.150 |
Why?
| Leukemia, Myeloid, Acute | 2 | 2022 | 534 | 0.150 |
Why?
| Glucocorticoids | 1 | 2022 | 554 | 0.150 |
Why?
| Cyclic S-Oxides | 1 | 2016 | 1 | 0.150 |
Why?
| Niclosamide | 1 | 2016 | 1 | 0.150 |
Why?
| Glycoproteins | 2 | 2011 | 323 | 0.150 |
Why?
| Oncogene Proteins, Fusion | 1 | 2019 | 182 | 0.150 |
Why?
| Fluorescence Polarization | 1 | 2016 | 35 | 0.150 |
Why?
| Lysine | 2 | 2023 | 251 | 0.150 |
Why?
| G2 Phase Cell Cycle Checkpoints | 1 | 2016 | 41 | 0.140 |
Why?
| M Phase Cell Cycle Checkpoints | 1 | 2016 | 23 | 0.140 |
Why?
| Parkinson Disease | 1 | 2020 | 346 | 0.140 |
Why?
| MicroRNAs | 1 | 2023 | 661 | 0.140 |
Why?
| Antioxidants | 2 | 2011 | 581 | 0.140 |
Why?
| Quantitative Structure-Activity Relationship | 1 | 2015 | 13 | 0.140 |
Why?
| Antiviral Agents | 1 | 2022 | 670 | 0.140 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2013 | 135 | 0.140 |
Why?
| Immunity, Innate | 1 | 2022 | 762 | 0.140 |
Why?
| Oxidation-Reduction | 5 | 2020 | 931 | 0.140 |
Why?
| Molecular Sequence Data | 7 | 2014 | 2933 | 0.140 |
Why?
| Crystallography, X-Ray | 5 | 2017 | 430 | 0.140 |
Why?
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2015 | 9 | 0.130 |
Why?
| Drug Design | 1 | 2016 | 163 | 0.130 |
Why?
| Retinaldehyde | 1 | 2014 | 7 | 0.130 |
Why?
| Allosteric Regulation | 3 | 2023 | 87 | 0.130 |
Why?
| Acetaldehyde | 1 | 2014 | 20 | 0.130 |
Why?
| HeLa Cells | 1 | 2016 | 609 | 0.130 |
Why?
| Cells, Cultured | 3 | 2020 | 4162 | 0.130 |
Why?
| Alzheimer Disease | 1 | 2020 | 513 | 0.130 |
Why?
| Drug Discovery | 1 | 2016 | 128 | 0.130 |
Why?
| Sulfhydryl Compounds | 2 | 2020 | 190 | 0.130 |
Why?
| Membrane Proteins | 2 | 2011 | 1093 | 0.130 |
Why?
| DNA Repair | 1 | 2016 | 203 | 0.130 |
Why?
| Mass Spectrometry | 4 | 2012 | 686 | 0.130 |
Why?
| Recombinant Proteins | 5 | 2011 | 1318 | 0.120 |
Why?
| Pituitary Neoplasms | 1 | 2015 | 166 | 0.120 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 839 | 0.120 |
Why?
| Computer Simulation | 4 | 2014 | 945 | 0.120 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2014 | 97 | 0.120 |
Why?
| Heat-Shock Proteins | 1 | 2014 | 129 | 0.120 |
Why?
| Fatty Liver, Alcoholic | 1 | 2013 | 16 | 0.120 |
Why?
| Mammary Glands, Animal | 2 | 2011 | 123 | 0.120 |
Why?
| Protein Folding | 2 | 2014 | 255 | 0.120 |
Why?
| Adenosine Triphosphatases | 1 | 2014 | 160 | 0.120 |
Why?
| Lactation | 2 | 2011 | 162 | 0.110 |
Why?
| Antimetabolites, Antineoplastic | 1 | 2013 | 85 | 0.110 |
Why?
| Hypoxanthine Phosphoribosyltransferase | 1 | 2013 | 26 | 0.110 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2014 | 162 | 0.110 |
Why?
| Inflammation | 2 | 2022 | 2598 | 0.110 |
Why?
| Cell Cycle | 2 | 2014 | 584 | 0.110 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1402 | 0.110 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 336 | 0.110 |
Why?
| Electron Transport Complex I | 1 | 2012 | 37 | 0.110 |
Why?
| Status Epilepticus | 1 | 2012 | 34 | 0.110 |
Why?
| Gene Expression Regulation | 3 | 2013 | 2491 | 0.110 |
Why?
| Gout | 1 | 2013 | 57 | 0.110 |
Why?
| PTEN Phosphohydrolase | 1 | 2013 | 149 | 0.110 |
Why?
| Fatty Acid-Binding Proteins | 1 | 2012 | 61 | 0.110 |
Why?
| Glutathione Reductase | 1 | 2011 | 22 | 0.110 |
Why?
| Acridines | 1 | 2011 | 7 | 0.110 |
Why?
| Glutathione Peroxidase | 1 | 2011 | 53 | 0.100 |
Why?
| DNA Topoisomerases, Type II | 1 | 2011 | 45 | 0.100 |
Why?
| Glutathione Transferase | 1 | 2011 | 98 | 0.100 |
Why?
| Flavoproteins | 1 | 2011 | 7 | 0.100 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 196 | 0.100 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 432 | 0.100 |
Why?
| Apoptosis | 6 | 2021 | 2532 | 0.100 |
Why?
| Glycolipids | 1 | 2011 | 38 | 0.100 |
Why?
| Mitochondria, Liver | 1 | 2011 | 77 | 0.100 |
Why?
| Transcriptional Activation | 1 | 2013 | 360 | 0.100 |
Why?
| Xenograft Model Antitumor Assays | 4 | 2021 | 747 | 0.100 |
Why?
| Organelles | 1 | 2011 | 55 | 0.100 |
Why?
| Myocytes, Cardiac | 1 | 2015 | 483 | 0.100 |
Why?
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 99 | 0.100 |
Why?
| Indoles | 2 | 2015 | 318 | 0.090 |
Why?
| Hydrogen Peroxide | 1 | 2012 | 299 | 0.090 |
Why?
| Sirtuin 3 | 1 | 2011 | 60 | 0.090 |
Why?
| Carcinoma, Hepatocellular | 1 | 2012 | 231 | 0.090 |
Why?
| Superoxide Dismutase | 1 | 2012 | 345 | 0.090 |
Why?
| Milk | 1 | 2011 | 127 | 0.090 |
Why?
| Brain | 2 | 2012 | 2540 | 0.090 |
Why?
| Enzyme Activation | 2 | 2013 | 864 | 0.090 |
Why?
| Protein Processing, Post-Translational | 1 | 2012 | 421 | 0.090 |
Why?
| Breast Neoplasms | 2 | 2020 | 1994 | 0.090 |
Why?
| Kinetics | 1 | 2013 | 1658 | 0.090 |
Why?
| Thioredoxin-Disulfide Reductase | 1 | 2009 | 14 | 0.090 |
Why?
| Cell Movement | 1 | 2014 | 929 | 0.090 |
Why?
| Phospholipids | 1 | 2011 | 211 | 0.090 |
Why?
| Adenosine Triphosphate | 1 | 2011 | 456 | 0.090 |
Why?
| Oxidative Stress | 2 | 2014 | 1204 | 0.090 |
Why?
| Peroxiredoxin VI | 1 | 2008 | 5 | 0.090 |
Why?
| Tumor Cells, Cultured | 3 | 2022 | 904 | 0.080 |
Why?
| Protein Structure, Tertiary | 4 | 2014 | 832 | 0.080 |
Why?
| Down-Regulation | 1 | 2011 | 654 | 0.080 |
Why?
| Protein Interaction Domains and Motifs | 3 | 2013 | 141 | 0.080 |
Why?
| Quinones | 1 | 2007 | 12 | 0.080 |
Why?
| Cross-Linking Reagents | 1 | 2008 | 190 | 0.080 |
Why?
| Mutation | 4 | 2021 | 3493 | 0.080 |
Why?
| Lipid Metabolism | 1 | 2011 | 482 | 0.080 |
Why?
| DNA-Binding Proteins | 2 | 2013 | 1384 | 0.080 |
Why?
| Spectrophotometry, Infrared | 1 | 2007 | 54 | 0.080 |
Why?
| NF-kappa B p50 Subunit | 1 | 2007 | 26 | 0.080 |
Why?
| Acrolein | 1 | 2007 | 25 | 0.080 |
Why?
| Galactosides | 1 | 2006 | 3 | 0.070 |
Why?
| Cell Membrane | 1 | 2011 | 741 | 0.070 |
Why?
| Energy Metabolism | 1 | 2012 | 783 | 0.070 |
Why?
| beta-Galactosidase | 1 | 2006 | 67 | 0.070 |
Why?
| Substrate Specificity | 3 | 2014 | 375 | 0.070 |
Why?
| Arginine | 3 | 2013 | 254 | 0.070 |
Why?
| Carcinoma | 1 | 2007 | 212 | 0.070 |
Why?
| Nitroimidazoles | 1 | 2005 | 7 | 0.070 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2007 | 513 | 0.060 |
Why?
| Biological Availability | 1 | 2005 | 129 | 0.060 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 3 | 2011 | 171 | 0.060 |
Why?
| Computational Biology | 1 | 2008 | 601 | 0.060 |
Why?
| Aldehyde Dehydrogenase, Mitochondrial | 2 | 2014 | 32 | 0.060 |
Why?
| Mice, Nude | 2 | 2021 | 668 | 0.060 |
Why?
| Polycomb-Group Proteins | 1 | 2023 | 36 | 0.060 |
Why?
| Mice, Inbred C57BL | 4 | 2014 | 5020 | 0.060 |
Why?
| Benzamides | 1 | 2023 | 175 | 0.060 |
Why?
| Peptides | 2 | 2023 | 893 | 0.060 |
Why?
| Exoribonucleases | 1 | 2023 | 40 | 0.060 |
Why?
| Insulin Resistance | 1 | 2011 | 1192 | 0.050 |
Why?
| Disease Models, Animal | 3 | 2022 | 3799 | 0.050 |
Why?
| Molecular Conformation | 2 | 2015 | 148 | 0.050 |
Why?
| Phospholipase C beta | 1 | 2022 | 28 | 0.050 |
Why?
| Alcohols | 1 | 2022 | 32 | 0.050 |
Why?
| Mesocricetus | 1 | 2022 | 33 | 0.050 |
Why?
| Hep G2 Cells | 2 | 2013 | 74 | 0.050 |
Why?
| Ear | 1 | 2022 | 33 | 0.050 |
Why?
| Ethanol | 3 | 2012 | 584 | 0.050 |
Why?
| Stress, Physiological | 2 | 2015 | 433 | 0.050 |
Why?
| Peptide Mapping | 2 | 2012 | 65 | 0.050 |
Why?
| High-Throughput Screening Assays | 1 | 2023 | 126 | 0.050 |
Why?
| Serine Endopeptidases | 1 | 2022 | 104 | 0.050 |
Why?
| Oximes | 1 | 2021 | 18 | 0.050 |
Why?
| Sequence Alignment | 2 | 2012 | 343 | 0.050 |
Why?
| Perilipin-2 | 2 | 2011 | 36 | 0.050 |
Why?
| Oxidative Phosphorylation | 1 | 2022 | 160 | 0.050 |
Why?
| Angiogenesis Inhibitors | 1 | 2003 | 223 | 0.050 |
Why?
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 98 | 0.050 |
Why?
| Indazoles | 1 | 2021 | 61 | 0.050 |
Why?
| Cell-Free System | 2 | 2011 | 53 | 0.050 |
Why?
| Neural Crest | 1 | 2022 | 145 | 0.050 |
Why?
| Viral Load | 1 | 2022 | 423 | 0.050 |
Why?
| Antibodies, Monoclonal | 1 | 2006 | 1306 | 0.050 |
Why?
| HEK293 Cells | 2 | 2013 | 651 | 0.050 |
Why?
| Blotting, Western | 2 | 2013 | 1225 | 0.040 |
Why?
| Lipoproteins | 1 | 2020 | 164 | 0.040 |
Why?
| Carbon | 1 | 2020 | 175 | 0.040 |
Why?
| T-Lymphocytes | 1 | 2007 | 1814 | 0.040 |
Why?
| MAP Kinase Signaling System | 1 | 2021 | 304 | 0.040 |
Why?
| Tandem Mass Spectrometry | 2 | 2013 | 423 | 0.040 |
Why?
| Microglia | 1 | 2020 | 214 | 0.040 |
Why?
| Anti-Bacterial Agents | 1 | 2008 | 1562 | 0.040 |
Why?
| Piperazines | 1 | 2021 | 326 | 0.040 |
Why?
| Neoplasm Transplantation | 1 | 2019 | 248 | 0.040 |
Why?
| Genomics | 2 | 2014 | 714 | 0.040 |
Why?
| Female | 8 | 2022 | 63629 | 0.040 |
Why?
| Triglycerides | 1 | 2020 | 527 | 0.040 |
Why?
| Amyloid beta-Peptides | 1 | 2020 | 202 | 0.040 |
Why?
| Drug Resistance, Multiple | 1 | 2017 | 19 | 0.040 |
Why?
| Dimerization | 1 | 2017 | 184 | 0.040 |
Why?
| Child | 1 | 2016 | 19561 | 0.040 |
Why?
| Models, Biological | 2 | 2014 | 1756 | 0.030 |
Why?
| RNA, Messenger | 1 | 2023 | 2720 | 0.030 |
Why?
| Rats, Sprague-Dawley | 2 | 2012 | 2501 | 0.030 |
Why?
| Nitroglycerin | 1 | 2014 | 24 | 0.030 |
Why?
| Circular Dichroism | 1 | 2015 | 138 | 0.030 |
Why?
| Adult | 1 | 2016 | 32385 | 0.030 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2014 | 76 | 0.030 |
Why?
| Unfolded Protein Response | 1 | 2014 | 48 | 0.030 |
Why?
| Calorimetry | 1 | 2014 | 59 | 0.030 |
Why?
| Male | 6 | 2022 | 59639 | 0.030 |
Why?
| Magnesium | 1 | 2014 | 156 | 0.030 |
Why?
| Phenotype | 1 | 2022 | 3070 | 0.030 |
Why?
| Macrophages | 1 | 2020 | 1334 | 0.030 |
Why?
| Sequence Homology, Amino Acid | 1 | 2014 | 376 | 0.030 |
Why?
| Cell Cycle Checkpoints | 1 | 2013 | 89 | 0.030 |
Why?
| Lung | 2 | 2022 | 3830 | 0.030 |
Why?
| Retinoid X Receptors | 1 | 2013 | 38 | 0.030 |
Why?
| Caco-2 Cells | 1 | 2013 | 68 | 0.030 |
Why?
| RNA Splice Sites | 1 | 2013 | 39 | 0.030 |
Why?
| Synaptosomes | 1 | 2012 | 12 | 0.030 |
Why?
| Biotinylation | 1 | 2012 | 32 | 0.030 |
Why?
| Telomere | 1 | 2015 | 211 | 0.030 |
Why?
| Kainic Acid | 1 | 2012 | 31 | 0.030 |
Why?
| Anilino Naphthalenesulfonates | 1 | 2012 | 10 | 0.030 |
Why?
| Fishes | 1 | 2013 | 85 | 0.030 |
Why?
| Excitatory Amino Acid Agonists | 1 | 2012 | 39 | 0.030 |
Why?
| Tumor Microenvironment | 1 | 2015 | 457 | 0.030 |
Why?
| Methyltransferases | 1 | 2013 | 63 | 0.030 |
Why?
| Electron Transport Complex IV | 1 | 2012 | 54 | 0.030 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 241 | 0.030 |
Why?
| Anura | 1 | 2012 | 42 | 0.030 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 108 | 0.030 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2013 | 128 | 0.030 |
Why?
| Cysteine Proteinase Inhibitors | 1 | 2012 | 51 | 0.030 |
Why?
| Sulfonamides | 1 | 2015 | 455 | 0.030 |
Why?
| Molecular Weight | 1 | 2012 | 346 | 0.030 |
Why?
| Ubiquitination | 1 | 2012 | 91 | 0.030 |
Why?
| Gene Knockout Techniques | 1 | 2012 | 107 | 0.030 |
Why?
| Endoplasmic Reticulum | 1 | 2014 | 250 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2012 | 170 | 0.030 |
Why?
| Rats | 2 | 2012 | 5426 | 0.030 |
Why?
| Amination | 1 | 2011 | 2 | 0.030 |
Why?
| Inhibitory Concentration 50 | 1 | 2011 | 82 | 0.030 |
Why?
| Alkylation | 1 | 2011 | 19 | 0.030 |
Why?
| Genome, Human | 1 | 2014 | 392 | 0.030 |
Why?
| Oxidants | 1 | 2012 | 126 | 0.030 |
Why?
| Nucleic Acid Conformation | 1 | 2015 | 674 | 0.030 |
Why?
| Chromatography, Liquid | 1 | 2013 | 356 | 0.030 |
Why?
| Embryo, Mammalian | 1 | 2012 | 222 | 0.030 |
Why?
| Protein Subunits | 1 | 2012 | 215 | 0.030 |
Why?
| Lipid Droplets | 1 | 2011 | 21 | 0.030 |
Why?
| Immunohistochemistry | 1 | 2015 | 1727 | 0.020 |
Why?
| Glycogen Synthase Kinase 3 beta | 1 | 2011 | 62 | 0.020 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2013 | 202 | 0.020 |
Why?
| Binding, Competitive | 1 | 2011 | 205 | 0.020 |
Why?
| Metabolic Networks and Pathways | 1 | 2012 | 178 | 0.020 |
Why?
| Hyperuricemia | 1 | 2013 | 135 | 0.020 |
Why?
| Cloning, Molecular | 1 | 2012 | 551 | 0.020 |
Why?
| DNA Primers | 1 | 2012 | 540 | 0.020 |
Why?
| Ligands | 1 | 2013 | 582 | 0.020 |
Why?
| Mammary Glands, Human | 1 | 2011 | 61 | 0.020 |
Why?
| Glycogen Synthase Kinase 3 | 1 | 2011 | 83 | 0.020 |
Why?
| Lipid Peroxidation | 1 | 2011 | 151 | 0.020 |
Why?
| Membranes, Artificial | 1 | 2011 | 74 | 0.020 |
Why?
| NAD | 1 | 2011 | 68 | 0.020 |
Why?
| Acetylation | 1 | 2011 | 227 | 0.020 |
Why?
| Mammals | 1 | 2012 | 257 | 0.020 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 358 | 0.020 |
Why?
| Protein Structure, Secondary | 1 | 2011 | 341 | 0.020 |
Why?
| Transfection | 1 | 2012 | 909 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 1003 | 0.020 |
Why?
| In Vitro Techniques | 1 | 2011 | 1130 | 0.020 |
Why?
| DNA Breaks, Single-Stranded | 1 | 2009 | 5 | 0.020 |
Why?
| Hypoxia | 1 | 2015 | 1003 | 0.020 |
Why?
| Analysis of Variance | 1 | 2012 | 1329 | 0.020 |
Why?
| Phylogeny | 1 | 2012 | 830 | 0.020 |
Why?
| NADPH-Ferrihemoprotein Reductase | 1 | 2008 | 11 | 0.020 |
Why?
| Animal Feed | 1 | 2008 | 56 | 0.020 |
Why?
| Evolution, Molecular | 1 | 2012 | 459 | 0.020 |
Why?
| Microsomes, Liver | 1 | 2008 | 59 | 0.020 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 1183 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2013 | 1188 | 0.020 |
Why?
| Caspases | 1 | 2009 | 275 | 0.020 |
Why?
| Liver Neoplasms | 1 | 2012 | 546 | 0.020 |
Why?
| Oxygen | 1 | 2012 | 887 | 0.020 |
Why?
| Transcription Factor AP-1 | 1 | 2007 | 82 | 0.020 |
Why?
| Tetrazolium Salts | 1 | 2006 | 20 | 0.020 |
Why?
| NFATC Transcription Factors | 1 | 2007 | 83 | 0.020 |
Why?
| Indicators and Reagents | 1 | 2006 | 102 | 0.020 |
Why?
| Mitochondria | 1 | 2012 | 809 | 0.020 |
Why?
| Cell Respiration | 1 | 2006 | 78 | 0.020 |
Why?
| Deoxyuridine | 1 | 2006 | 6 | 0.020 |
Why?
| Proteomics | 1 | 2012 | 890 | 0.020 |
Why?
| Thiazoles | 1 | 2006 | 125 | 0.020 |
Why?
| Cysteine | 1 | 2007 | 187 | 0.020 |
Why?
| Smoke | 1 | 2007 | 146 | 0.020 |
Why?
| Drug Carriers | 1 | 2006 | 118 | 0.020 |
Why?
| Superoxides | 1 | 2006 | 225 | 0.020 |
Why?
| Drug Interactions | 1 | 2006 | 356 | 0.020 |
Why?
| Colonic Neoplasms | 1 | 2006 | 230 | 0.020 |
Why?
| Drug Delivery Systems | 1 | 2006 | 312 | 0.010 |
Why?
| Oxygen Consumption | 1 | 2006 | 613 | 0.010 |
Why?
| Respiratory Tract Infections | 1 | 2007 | 335 | 0.010 |
Why?
| Time Factors | 1 | 2012 | 6682 | 0.010 |
Why?
| Liver | 1 | 2008 | 1827 | 0.010 |
Why?
| Aged | 1 | 2019 | 20495 | 0.010 |
Why?
| Child, Preschool | 1 | 2014 | 9755 | 0.010 |
Why?
| Cytokines | 1 | 2007 | 1928 | 0.010 |
Why?
| Middle Aged | 1 | 2019 | 28563 | 0.010 |
Why?
|
|
Reigan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|